New drug duo tested in fight against stubborn leukemia
Disease control
Recruiting now
This early-stage study is testing whether combining an experimental drug (DFP-10917) with an approved drug (venetoclax) is safe and effective for adults with acute myeloid leukemia (AML) that has come back or not responded to previous treatments. The first part of the study aims …
Phase: PHASE1, PHASE2 • Sponsor: Delta-Fly Pharma, Inc. • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC